11/20/2026 | Press release | Distributed by Public on 11/20/2026 05:05
November 20, 2026
Securities and Exchange Commission
100 F Street, N.E.
Washington, DC 20549
Commissioners:
We have read the statements made by Alterity Therapeutics Limited (copy attached), which we understand will be filed with the Securities and Exchange Commission, pursuant to Form 6-K concerning the change in its certifying accountant and provided in response to Item 16F(a) of Form 20-F of Alterity Therapeutics Limited dated November 20, 2026. We agree with the statements concerning our Firm contained therein.
Very truly yours
/s/ PricewaterhouseCoopers
Melbourne, Australia
Attachment
|
pwc.com.au |
PricewaterhouseCoopers, ABN 52 780 433 757 Liability limited by a scheme approved under Professional Standards Legislation. |